Back
Recursion Pharmaceuticals Stock Predictions
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
37
RXRX
Recursion Pharmaceuticals
Last Price:
$7.28
Seasonality Move:
-18.3%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Recursion Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 20.6% based on the past 3 years of stock performance.
-
Recursion Pharmaceuticals has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Recursion Pharmaceuticals Stock Undervalued?The current Recursion Pharmaceuticals [RXRX] share price is $6.99. The Score for RXRX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
RXRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Recursion Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 20.6% based on the past 3 years of stock performance.
Recursion Pharmaceuticals Stock Rating
Sell
37
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals overpriced?
-
Recursion Pharmaceuticals has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Recursion Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
recursion.com
52-Week Data
52-Week High:
15.74
52-Week Low:
5.60
Prediction Charts
Market Cap:
2B
Price in USD:
6.99
Volume:
20.6M
Beta:
0.86
Technical Analysis
SMA50:
6.77
SMA100:
6.73
SMA200:
7.78
52-Wk Change:
-32.27%
Stock Predictions
-
Is Recursion Pharmaceuticals stock public?Yes, Recursion Pharmaceuticals is a publicly traded company.
-
What is the Recursion Pharmaceuticals stock quote today?The Recursion Pharmaceuticals stock price is 6.99 USD today.
-
How to buy Recursion Pharmaceuticals stock online?You can buy Recursion Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-4 | 7.18 | 7.13 | 7.45 | 7.02 |
| Dec-5 | 7.12 | 6.59 | 7.14 | 6.56 |
| Dec-6 | 6.80 | 8.01 | 8.15 | 6.70 |
| Dec-9 | 8.81 | 8.27 | 9.55 | 8.17 |
| Dec-10 | 8.17 | 7.46 | 8.22 | 7.28 |
| Dec-11 | 7.89 | 7.57 | 7.89 | 7.23 |
| Dec-12 | 7.52 | 6.98 | 7.53 | 6.97 |
| Dec-13 | 7.11 | 6.95 | 7.14 | 6.75 |
| Dec-16 | 7.10 | 7.44 | 7.85 | 6.86 |
| Dec-17 | 7.45 | 7.12 | 7.47 | 6.95 |
| Dec-18 | 7.14 | 6.22 | 7.14 | 6.04 |
| Dec-19 | 6.51 | 6.09 | 6.53 | 6.03 |
| Dec-20 | 6.00 | 6.04 | 6.20 | 5.93 |
| Dec-23 | 6.16 | 6.99 | 7.01 | 6.10 |
Recursion Pharmaceuticals Earnings
Recursion Pharmaceuticals Earnings Report: Per Share Recursion Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Recursion Pharmaceuticals Forecast Revenue Growth
Recursion Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Recursion Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.